POTASSIUM ACETATE Drug Patent Profile
✉ Email this page to a colleague
When do Potassium Acetate patents expire, and what generic alternatives are available?
Potassium Acetate is a drug marketed by Exela Pharma and Hospira and is included in three NDAs.
The generic ingredient in POTASSIUM ACETATE is potassium acetate. There are two hundred and forty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the potassium acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Potassium Acetate
A generic version of POTASSIUM ACETATE was approved as potassium acetate by HOSPIRA on July 20th, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POTASSIUM ACETATE?
- What are the global sales for POTASSIUM ACETATE?
- What is Average Wholesale Price for POTASSIUM ACETATE?
Summary for POTASSIUM ACETATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 159 |
| Clinical Trials: | 18 |
| Patent Applications: | 4,729 |
| Drug Prices: | Drug price information for POTASSIUM ACETATE |
| What excipients (inactive ingredients) are in POTASSIUM ACETATE? | POTASSIUM ACETATE excipients list |
| DailyMed Link: | POTASSIUM ACETATE at DailyMed |
Recent Clinical Trials for POTASSIUM ACETATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mahidol University | N/A |
| Fayoum University Hospital | Phase 4 |
| National Cheng-Kung University Hospital | N/A |
Pharmacology for POTASSIUM ACETATE
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Anatomical Therapeutic Chemical (ATC) Classes for POTASSIUM ACETATE
US Patents and Regulatory Information for POTASSIUM ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma | POTASSIUM ACETATE | potassium acetate | INJECTABLE;INJECTION | 206203-001 | Dec 29, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Exela Pharma | POTASSIUM ACETATE | potassium acetate | INJECTABLE;INJECTION | 212692-001 | Oct 20, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | POTASSIUM ACETATE | potassium acetate | INJECTABLE;INJECTION | 018896-001 | Jul 20, 1984 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
